Speratum Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include ImmPACT-Bio.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 1123% decrease | Employees 845% decrease |
Funding | ||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
ImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company